Efectos adversos de la resonancia magnética

52. Speit, G.; Schutz, P.; Hoffmann, H. Genotoxic effects of exposure to radiofrequency electromagnetic fields (RF-EMF) in cultured mammalian cells are not independently reproducible. Mutat. Res. 2007, 626, 42-47.
53. Lantow, M.; Viergutz, T.; Weiss, D.G.; Simkó, M. Comparative study of cell cycle kinetics and induction of apoptosis or necrosis after exposure to radiofrequency radiation in human Mono Mac 6 cells. Radiat. Res. 2006c, 166, 539-543.
54. Caraglia, M.; Marra, M.; Mancinelli, F.; D’Ambrosio, G.; Massa, R.; Giordano, A.; Budillon, A.; Abbruzzese, A.; Bismuto, E. Electromagnetic fields at mobile phone frequency induce apoptosis and inactivation of the multi-chaperone complex in human epidermoid cancer cells. J. Cell. Physiol. 2005, 204, 39-48.
55. Scarfì, M.R.; Fresegna, A.M.; Villani, P.; Pinto, R.; Marino, C.; Sarti, M.; Altavista, P.; Sannino, A.; Lovisolo, G.A. Exposure to radiofrequency radiation (900 MHz, GSM signal) does not affect micronucleus frequency and cell proliferation in human peripheral blood lymphocytes: an interlaboratory study. Radiat. Res. 2006, 165, 655-663.
56. Zeni, O.; Schiavoni, A.; Perrotta, A.; Forigo, D.; Depilano, M.; Scarfi, M.R. Evaluation of genotoxic effects in human leukocytes after in vitro exposure to 1950 MHz UMTS radiofrequency field. Bioelectromagnetics 2008, 29, 177-184.
57. Repacholi MH, Lerchl A, Röösli M, Sienkiewicz Z, Auvinen A, Breckenkamp J, d’Inzeo G, Elliott P, Frei P, Heinrich S, Lagroye I, Lahkola A, McCormick DL, Thomas S, Vecchia P. Systematic review of wireless phone use and brain cancer and other head tumors. Bioelectromagnetics. 2012 Apr;33(3):187-206. doi: 10.1002/bem.20716. Epub 2011 Oct 21.
58. Levis AG, Minicuci N, Ricci P, Gennaro V, Garbisa S. Mobile phones and head tumours. The discrepancies in cause-effect relationships in the epidemiological studies – how do they arise? Environ Health. 2011 Jun 17;10:59.
59. Cardis E, Armstrong BK, Bowman JD, Giles GG, Hours M, Krewski D, McBride M, Parent ME, Sadetzki S, Woodward A, Brown J, Chetrit A, Figuerola J, Hoffmann C, Jarus-Hakak A, Montestruq L, Nadon L, Richardson L, Villegas R, Vrijheid M. Risk of brain tumours in relation to estimated RF dose from mobile phones: results from five Interphone countries. Occup Environ Med. 2011 Sep;68(9):631-40. Epub 2011 Jun 9.
60. Christ, A.; Kuster, N. Differences in RF energy absorption in the heads of adults and children. Bioelectromagnetics 2005, 7, S31-44.
61. Regel, S.J.; Negovetic, S.; Röösli, M.; Berdinas, V.; Schuderer, J.; Huss, A.; Lott, U.; Kuster, N.; Achermann, P. UMTS base station-like exposure, well being and cognitive performance. Environ. Health Perspect. 2006, 114, 1270-1275.
62. Agarwal A, Desai NR, Makker K, Varghese A, Mouradi R, Sabanegh E, Sharma R. Effects of radiofrequency electromagnetic waves (RF-EMW) from cellular phones on human ejaculated semen: an in vitro pilot study. Fertil Steril. 2009 Oct;92(4):1318-25. Epub 2008 Sep 20.
63. La Vignera S, Condorelli RA, Vicari E, D’Agata R, Calogero AE. Effects of the exposure to mobile phones on male reproduction: a review of the literature. J Androl. 2012 May-Jun;33(3):350-6. Epub 2011 Jul 28.
64. Jung JW, Kang HR, Kim MH, Lee W, Min KU, Han MH, Cho SH. Immediate hypersensitivity reaction to gadolinium-based MR contrast media. Radiology. 2012 Aug;264(2):414-22. doi: 10.1148/ radiol.12112025. Epub 2012 May 1.
65. Li A, Wong CS, Lee CM, Au Yeung MC. Acute adverse reactions to magnetic resonance contrast media – gadolinium chelates. British Journal of Radiology 2006; 79: 368–71.
66. Perazella MA. Current status of gadolinium toxicity in patients with kidney disease. Clin J Am Soc Nephrol. 2009 Feb;4(2):461-9. doi: 10.2215/CJN.06011108.
67. Vassallo DV, Simões MR, Furieri LB, Fioresi M, Fiorim J, Almeida EA, Angeli JK, Wiggers GA, Peçanha FM, Salaices M. Toxic effects of mercury, lead and gadolinium on vascular reactivity. Braz J Med Biol Res. 2011 Sep;44(9):939-46. Epub 2011 Aug 12.
68. Pia C. Sundgren, MD, PhD and Peter Leander, MD, PhD. Is Administration of Gadolinium-Based Contrast Media to Pregnant Women and Small Children Justified? Journal of Magnetic Resonance Imaging 34:750–757 (2011)
69. Drug Safety Update 2010; 3: 3–5 http://www.mhra.gov.uk/Publications/Safetyguidance/DrugSafetyUpdate/ CON068297
70. Loren A. Zaremba, Ph.D. Criteria for Significant Risk Investigations of Magnetic Resonance Diagnostic Devices. U.S. Department of Health and Human Services Food and Drug Administration Center for Devices and Radiological Health (2003).